Literature DB >> 33423916

Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose.

Shane R Mueller1, Jason M Glanz2, Anh P Nguyen3, Melanie Stowell4, Stephen Koester5, Deborah J Rinehart6, Ingrid A Binswanger7.   

Abstract

BACKGROUND: Despite policy efforts to prevent overdose, accidental overdoses among individuals prescribed opioids continue to occur. Guided by Rhodes' Risk Environment Framework, we examined the unintended consequences of restrictive policies by identifying macro policy and micro-level contextual factors that patients prescribed opioids for pain identified as contributing to overdose events.
METHODS: Semi-structured interviews were conducted with 31 patients prescribed opioids who experienced an accidental opioid overdose between April 2017 and June 2019 in two health systems.
RESULTS: We identified three interrelated factors that emerged within an evolving risk environment and may have increased patients' vulnerability for an accidental opioid overdose: desperation from persistent pain and comorbidities; limited knowledge about opioid medication safety and effectiveness; and restrictive opioid prescribing policies that exacerbated stigma, fear and mistrust and prevented open patient-clinician communication. When experiencing persistent pain, patients took matters into their own hands by taking more medications or in different intervals than prescribed, mixing them with other substances, or using illicitly obtained opioids.
CONCLUSION: For some patients, macro-level policies and guidelines designed to reduce opioid overdoses by restricting opioid supply may have paradoxically created a micro-level risk environment that contributed to overdose events in a subset of patients.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Opioid overdose; Opioid tapering; Policy; Qualitative; Risk environment

Mesh:

Substances:

Year:  2021        PMID: 33423916      PMCID: PMC9134796          DOI: 10.1016/j.drugpo.2020.103077

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  44 in total

1.  The patient-provider relationship in chronic pain care: providers' perspectives.

Authors:  Marianne S Matthias; Amy L Parpart; Kathryn A Nyland; Monica A Huffman; Dawana L Stubbs; Christy Sargent; Matthew J Bair
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

2.  Perceived Unintended Consequences of Prescription Drug Monitoring Programs.

Authors:  Alden Yuanhong Lai; Katherine C Smith; Jon S Vernick; Corey S Davis; G Caleb Alexander; Lainie Rutkow
Journal:  Subst Use Misuse       Date:  2018-11-21       Impact factor: 2.164

3.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2019-02-02

4.  Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2014-08-22

Review 5.  The treatment of cancer pain.

Authors:  K M Foley
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

6.  Acceptance and values-based action in chronic pain: a study of treatment effectiveness and process.

Authors:  Kevin E Vowles; Lance M McCracken
Journal:  J Consult Clin Psychol       Date:  2008-06

7.  When People You Love Are The Unintended Consequences Of Opioid Policy.

Authors:  Mary Beth Foglia
Journal:  Health Aff (Millwood)       Date:  2019-12       Impact factor: 6.301

8.  Prescribing Opioids for Chronic Pain: Unintended Consequences of the 2016 CDC Guideline.

Authors:  Robert L Chuck Rich
Journal:  Am Fam Physician       Date:  2020-04-15       Impact factor: 3.292

Review 9.  Validating pain communication: current state of the science.

Authors:  Sara N Edmond; Francis J Keefe
Journal:  Pain       Date:  2015-02       Impact factor: 7.926

10.  An ethnography of chronic pain management in primary care: The social organization of physicians' work in the midst of the opioid crisis.

Authors:  Fiona Webster; Kathleen Rice; Joel Katz; Onil Bhattacharyya; Craig Dale; Ross Upshur
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

View more
  5 in total

1.  Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina.

Authors:  Bethany L DiPrete; Shabbar I Ranapurwala; Courtney N Maierhofer; Naoko Fulcher; Paul R Chelminski; Christopher L Ringwalt; Timothy J Ives; Nabarun Dasgupta; Vivian F Go; Brian W Pence
Journal:  JAMA Netw Open       Date:  2022-04-01

2.  Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions.

Authors:  Daniel M Hartung; Jonah Geddes; Sara E Hallvik; P Todd Korthuis; Luke Middleton; Gillian Leichtling; Christi Hildebran; Hyunjee Kim
Journal:  BMC Health Serv Res       Date:  2022-01-14       Impact factor: 2.655

3.  Clinical and neuroscience evidence supports the critical importance of patient expectations and agency in opioid tapering.

Authors:  Beth D Darnall; Howard L Fields
Journal:  Pain       Date:  2022-05-01       Impact factor: 6.961

4.  Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran.

Authors:  Bahram Armoon; Mark D Griffiths; Azadeh Bayani; Rasool Mohammadi; Elaheh Ahounbar
Journal:  Addict Sci Clin Pract       Date:  2022-08-04

5.  "The DEA would come in and destroy you": a qualitative study of fear and unintended consequences among opioid prescribers in WV.

Authors:  Cara L Sedney; Treah Haggerty; Patricia Dekeseredy; Divine Nwafor; Martina Angela Caretta; Henry H Brownstein; Robin A Pollini
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.